Number of Shares
10.11 Mil
Current Holdings Value*
$63.39 Mil
% of Portfolio
2.9%
Total Estimate Gain
$-54.11 Mil
% of Total Estimate Gain
-39.12%

Frazier Life Sciences Management, L.P.'s Phathom Pharmaceuticals Inc Holding Summary

As of 2025-03-31, Frazier Life Sciences Management, L.P. held 10.11 Mil shares of Phathom Pharmaceuticals Inc(PHAT), totaling $63.39 Mil. This investment constitutes 2.9% of their stock portfolio, and Frazier Life Sciences Management, L.P. now holds 14.48% of the outstanding Phathom Pharmaceuticals Inc(PHAT) stock.

The initial trade took place in 2022Q1. And since then Frazier Life Sciences Management, L.P. has made 2 purchases of PHAT, at an average price of $13.68, for a total of 10.11 Mil shares. Based on historical transaction data and PHAT's current price of $8.33, Frazier Life Sciences Management, L.P.'s estimated gain on his PHAT holdings is $-54.11 Mil, reflecting a -39.12% gain to date.

Frazier Life Sciences Management, L.P. PHAT ($8.33) Holding Chart

Frazier Life Sciences Management, L.P. PHAT ($8.33) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1